Online citations, reference lists, and bibliographies.
← Back to Search

The Use Of Botulinum Toxin In Blepharospasm.

N. Shorr, S. Seiff, J. Kopelman
Published 1985 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Twenty-two patients, 17 with benign essential blepharospasm and five with hemifacial spasm, received botulinum toxin by subcutaneous injections in the eyelids and eyebrows. All 22 patients received a standard treatment of 12.5 units of botulinum toxin per side at each injection session. The orbicularis oculi muscle showed pronounced weakness after injection and the spasms decreased. Spasms often recurred despite persistent orbicularis oculi muscle weakness. Side effects were minimal. All patients received some relief, which generally lasted six to 12 weeks.
This paper references



This paper is referenced by
10.1097/ICU.0b013e3282be9032
What is new in the era of focal dystonia treatment? Botulinum injections and more
A. Çetinkaya (2007)
10.1097/00055735-200310000-00003
Chemodenervation for facial dystonias and wrinkles
A. Harrison (2003)
10.1046/J.1524-4725.2001.01038.X
Botulinum‐A Toxin Treatment of the Lower Eyelid Improves Infraorbital Rhytides and Widens the Eye
T. Flynn (2001)
10.1001/ARCHOTOL.1988.01860240057024
Management of facial spasm with Clostridium botulinum toxin, type A (Oculinum)
A. W. Biglan (1988)
10.1016/S0161-6420(87)33337-8
Use of botulinum toxin in the treatment of one hundred patients with facial dyskinesias.
J. Mauriello (1987)
10.1590/S0004-27492006000100005
Blefarospasmo essencial e espasmo hemifacial: características dos pacientes, tratamento com toxina botulínica A e revisão da literatura
S. Schellini (2006)
Relevant influential factors and therapeutic efficacy evaluation of microvascular decompression for hemifacial spasm
Zeng-Liang Liu (2016)
10.1016/S0002-9394(03)00075-8
Quantitative changes in botulinum toxin a treatment over time in patients with essential blepharospasm and idiopathic hemifacial spasm.
M. Snir (2003)
10.3109/08820539209065092
Botulinum toxin in ophthalmology
J. Holmes (1992)
10.1007/978-3-319-56038-0_8
Clinical Uses of the Botulinum Toxin and Ophthalmology
Jennifer A. Galvin (2018)
10.1017/S0317167100027748
Botulinum toxin injections in the treatment of blepharospasm, hemifacial spasm, and eyelid fasciculations.
S. Kraft (1988)
10.1016/S0161-6420(88)32977-5
Long-term results and complications of botulinum A toxin in the treatment of blepharospasm.
J. Dutton (1988)
10.1136/bjo.82.5.528
Botulinum toxin A treatment of overactive corrugator supercilii in thyroid eye disease
J. Olver (1998)
10.1017/S0317167100010817
Long-term efficacy of botulinum a toxin for blepharospasm and hemifacial spasm.
Harmeet S. Gill (2010)
10.1111/j.1442-9071.2010.02303.x
Difference in response to botulinum toxin type A treatment between patients with benign essential blepharospasm and hemifacial spasm
P. Cannon (2010)
10.1111/aos.12002
Tear production and drainage after botulinum toxin A injection in patients with essential blepharospasm
D. I. Park (2013)
10.1136/BJO.75.12.737
Natural history of treatment of facial dyskinesias with botulinum toxin: a study of 50 consecutive patients over seven years.
J. Mauriello (1991)
10.1007/s00702-010-0546-9
Difficulties with differentiating botulinum toxin treatment effects in essential blepharospasm
B. Wabbels (2010)
10.1111/J.1524-4725.2004.30556.X
Dry Eyes and Superficial Punctate Keratitis: A Complication of Treatment of Glabelar Dynamic Rhytides with Botulinum Exotoxin A
M. Northington (2004)
10.1592/phco.20.13.1079.35040
Pharmacotherapy with Botulinum Toxin: Harnessing Nature's Most Potent Neurotoxin
M. Bell (2000)
10.1016/J.OTC.2005.03.005
Botulinum toxin management of upper facial rhytidosis and blepharospasm.
S. Seiff (2005)
10.1002/MDS.870020402
Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm
M. Brin (1987)
10.1016/S0161-6420(95)30757-9
Long-term changes in duration of relief with botulinum toxin treatment of essential blepharospasm and hemifacial spasm.
J. Ainsworth (1995)
10.1016/J.MEDCLI.2012.12.015
Aplicaciones de la toxina botulínica en Neurología
Pedro José García-Ruiz (2013)
10.1016/j.wjam.2019.12.001
Acupuncture for 14 cases of Meige's syndrome II
Mi-mi Li (2019)
10.1097/01.smj.0000220888.88722.ab
Effectiveness of Repeated Treatment with Botulinum Toxin Type A Across Different Conditions
M. Gordon (2006)
[Costs and efficacy of type A botulinum toxin for the treatment of essential blepharospasm and hemifacial spasm].
Cintia Gomes Galvão Lasalvia (2006)
10.1016/0002-9394(88)90016-5
Negative antibody response to long-term treatment of facial spasm with botulinum toxin.
R. Gonnering (1988)
10.3390/toxins11020066
A Review of Periocular Botulinum Neurotoxin on the Tear Film Homeostasis and the Ocular Surface Change
Ren-Wen Ho (2019)
10.4274/tjo.27879
Long-Term Effect of Botulinum Toxin in the Treatment of Benign Essential Blepharospasm and Hemifacial Spasm
M. Akdemir (2015)
10.1016/S0039-6257(97)81995-9
Botulinum-A toxin in the treatment of craniocervical muscle spasms: short- and long-term, local and systemic effects.
J. Dutton (1996)
10.1016/S0733-8619(18)30311-6
Botulinum toxin therapy.
P. Savino (1991)
See more
Semantic Scholar Logo Some data provided by SemanticScholar